Psagot Value Holdings Ltd. Amgen Inc Transaction History

Psagot Value Holdings Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $65,595 - $81,438	300 Added 9.68%	3,400 $921,000
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $107,135 - $126,685	500 Added 19.23%	3,100 $686,000
Q1 2023 Jun 20, 2023	BUY	$225.79 - $275.2 $45,158 - $55,040	200 Added 8.33%	2,600 $622,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $242,084 - $307,597	1,057 Added 78.7%	2,400 $630,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $8,770 - $9,702	-40 Reduced 2.89%	1,343 $325,000
Q4 2021 Mar 14, 2022	SELL	$198.88 - $227.6 $612,550 - $701,008	-3,080 Reduced 69.01%	1,383 $949,000
Q3 2021 Mar 07, 2022	BUY	$212.27 - $248.7 $947,361 - $1.11 Million	4,463 New	4,463 $949,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.